NCT00716911View on ClinicalTrials.gov

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsNonneoplastic Condition
Interventions
DRUG

ganciclovir

GENETIC

polymerase chain reaction

OTHER

flow cytometry

OTHER

immunologic technique

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

allogeneic hematopoietic stem cell transplantation

PROCEDURE

assessment of therapy complications

PROCEDURE

peripheral blood stem cell transplantation

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

City of Hope Medical Center

OTHER

NCT00716911 - Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant | Biotech Hunter | Biotech Hunter